Expression of a novel human myotonin protein kinase (MtPK) cDNA clone which encodes a protein with a thymopoietin-like domain in COS cells  by Sasagawa, Noboru et al.
Expression 
cDNA 
of a novel human myotonin protein kinase (MtPK) 
clone which encodes a protein with a thymopoietin-like domain in 
Noboru Sasagawaa, Hiroyuki Sorimachi”, Kei Maruyamab, Kiichi Arahata”, Shoichi Ishiura”T*, 
Koichi Suzuki” 
FEES Letters 351 (1994) 22-26 
FEBS 14421 
COS cells 
“Institute of Molecular and Cellular Biosciences, the University of Tokyo, Tokyo 113, Japan 
bNational Institute for Physiological Sciences, Okazaki 444, Japan 
‘National Institute of Neuroscience, NCNR Kodaira. Tokyo 187, Japan 
Received 15 June 1994; revised version received 18 July 1994 
Abstract 
A full-length cDNA of human myotonin protein kinase (MtPK) was cloned and expressed in COS-1 cells. MtPK is recovered from the cytosolic 
fraction of the COS extract as a 70 kDa protein, which coincides with the size deduced from the predicted amino acid sequence. The sequence has 
a significant homology to thymopoietin, a peptide hormone of the thymus. Biochemical characteristics of MtPK expressed in COS-1 cells and its 
expression in rat tissues are investigated. 
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1. Introduction 
Myotonic Dystrophy (Dystrophia Myotonica, DM) is 
an autosomal dominant multi-systemic disorder with an 
estimated minimum incidence of 1 per 8,000 of the pop- 
ulation [l]. It is the commonest form of muscular dystro- 
phy affecting adults, charactarized primarily by 
myotonia and progressive muscle weakness, although 
the clinical manifestations vary significantly. Increased 
severity through the generations, anticipation, is also a 
unique feature of DM. The mutation underlying DM is 
the expansion of a polymorphic CTG repeat in the 3’- 
noncoding region of the gene mapping to chromosome 
19q13.3 [2-61. This DM cDNA has been cloned by sev- 
eral laboratories, and has been shown that the sequence 
has homology to serine-threonine protein kinase 
(MtPK), although there are minor discrepancies in the 
nucleotide and deduced amino acid sequences [2,7,16]. 
The exact function of MtPK protein remains, however, 
unknown. There are inconsistent reports concerning the 
length of the CTG repeats and the relationship of mRNA 
expression to disease severity [8-141; the number of CTG 
repeats in the normal population varies between 5 and 
37. (CTG),,,, could possess predisposing features mak- 
ing it a reservoir for new DM mutations. Decreased and 
increased disease expression has been reported as the 
number of CTG repeats increases. 
To investigate the role of CTG repeats in the expres- 
sion of the MtPK gene, we cloned a full-length cDNA 
for MtPK and its nucleotide sequence was determined. 
*Corresponding author. Fax: (81) (3) 3813 0654. 
MtPK expression has been analyzed by several groups, 
with apparently conflicting results concerning the levels 
of MtPK mRNA and protein products being obtained 
[4-61. Caskey et al. reported reduced mRNA levels in 
adult tissues using the RT-PCR method [ 10,121. Accord- 
ing to Korneluk, however, the increased mRNA levels in 
samples from congenital patients were striking [14]. An- 
tibodies against a fusion-protein of MtPK crossreact 
with a 55 kDa protein [ 12,151, a size slightly smaller than 
the value estimated from cDNA sequence analysis. In 
order to address these discrepancies, we transiently ex- 
pressed a full-length cDNA clone in COS-1 cells and 
examined protein expression by Western blot analysis. 
The expressed MtPK has a M.W of 70 kDa and the 
protein was isolated from the cytosolic fraction of trans- 
fected COS cells. 
2. Materials and methods 
2.1. Screening and sequencing of the MtPK cDNA clone 
Two overlapping clones corresponding to about 700 bp of the 5’ 
region and about 1,800 bp of the 3’ region of the MtPK cDNA clone 
were isolated from an adult human muscle cDNA library (CLON- 
TECH) using synthetic oligonucleotides (CGGCCCGGGGAGGGG- 
CCATGGTG and CCTGCAGGCTGTGGGCGGTGGG for 5’ re- 
gion [8] as PCR primers and oligos 101 and 102 in [2] for 3’ region as 
a probe). Each clone was digested with Sse8387I and a ligated full- 
length clone was introduced into pUCl18. The sequence of the MtPK 
full-length cDNA clone is shown in Fig. I. 
2.2. Expression in COS cells and Western blot analysis 
The MtPK cDNA obtained above was inserted into a vector pSRD, 
and transfected into COS-1 cells by the DEAE-dextran method. Elec- 
troporation was also used for more effective transfection. After 48 h 
incubation, transfected cells were harvested and sonicated in 20 mM 
Tris-HCl, pH 7.5, containing 0.1 M NaCl (buffer A). After centrifuga- 
tion at 15,000 x g for 3 min. the supernatant was used for enzyme assay. 
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The precipitate was resuspended in buffer A and used for assay. A part 
of the supernatant was solubilized in an SDS sample buffer (2% SDS, 
0.125 M Tris-HCI, pH 6.8, containing 30% glycerol, 5% 2-mercap- 
toethanol, and 0.02% Bromophenol blue) and boiled for 2 min. Samples 
were loaded onto 10% SDS polyacrylamide gels for electrophoresis. 
After electrophoresis, proteins were electroblotted onto nitrocellulose 
membranes, and the filters were soaked in antibody solution in 25 mM 
phosphate buffer, pH 7.4, containing 0.5 M NaCl and 0.05% Tween-20. 
Proteins were visualized with a VECTASTAIN ABC kit (rabbit IgG, 
Vector Lab). 
The antibodies used for analyses were raised in rabbits using peptides 
synthesized from the predicted peptide sequence as antigens. Antibody 
DMI recognizes MtPK amino acid residues 281-296 (DSTAETYG- 
KIVHYKEH), while antibodies DM5 and DM2 recognize the putative 
(LNPRTVFDSGAPLED) peptide corresponding to amino acid resi- 
dues 6233637 [7], which is now known to be a frame-shift product 
according to our sequence (PEP*NCLRLRGPVGR), and (EAEAR- 
NRDLEAHVRQ) corresponding to amino acid residues 500-514, re- 
spectively (Koga, R. et al., submitted). All peptides were synthesized 
by a peptide synthesizer (Applied Biosystems, Inc.). 
2.3. Enzyme assay 
Supematant fractions of transfected COS-1 cell extracts were im- 
munoprecipitated with anti-DMl antibody/Protein A-Sepharose. The 
precipitates were washed in a washing buffer (25 mM Tris-HCI, pH 7.5, 
containing 0.1 M NaCI, 20% glycerol, and 0.1% Nonidet P-40) three 
times and resuspended in buffer A. These immunoprecipitated samples 
were used for protein kinase and ATPase assays. 
2.4. In vitro phoshorylation assay of MiPK 
c-AMP, Ca, phospholipid and Ca, CaM-dependent protein kinase 
activities were determined. Phosphorylation of casein and auto- 
phosphorylation of MtPK itself were examined. Immunoprecipitated 
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protein samples were mixed with IO mM 2-mercaptoethanol, 20 mM 
ATP, 1 mCi [Y-~~P]ATP, 5 mM MgCl,, 0.15 M NaCl (total vol.: 40 ml). 
I mM c-AMP was added to determine c-AMP dependent protein ki- 
nase, 2 mM Ca’* and 2.5 mM CaM for Ca, CaM-dependent kinase, and 
2 mM Ca*‘, 4 mglml diolein, 50 mg/ml PIP,, and 50 mg/ml PS for Ca- 
and phospholipid-dependent kinase assays. Samples were incubated at 
30°C for 1 h and loaded onto SDS-PAGE (10% gels). The electrophor- 
esed gels were dried and analyzed by a Bio-Image analyzer (Fuji Film). 
2.5. In vivo phosphorylation assay 
Proteins in transfected COS-I cells were labeled directly by [3ZP]or- 
thophosphate. Confluent cells in a 6 cm-dish were first washed several 
times with saline, then 1 ml of non-P, medium containing 5% dialyzed 
serum (at 0.15 M NaCI) and 100 mCi/dish [“PJorthophosphate were 
added and the mixtures were incubated for 3 h. After washing, the 
‘*P-labeled cells were soaked in 0. I% Triton X-100 and the solubilized 
proteins were centrifuged at 15,000 x g for 3 min. The resultant super- 
natant was immunoprecipitated with anti-DM 1. Proteins were loaded 
on SDS-PAGE (10% gel) and electrophoresed gel was analyzed by 
Bio-Image Analyzer (Fuji Film). 
2.6. Assay of ATPase activity 
Immunoprecipitated sample was incubated in IO mM ATP, 50 mM 
Tris-HCl, pH 7.0, and metal ions. Four kinds of ions were examined; 
0.1 M NaCI, 16 mM CaCI,, 0.1 M KC1 and 5 mM MgCl, (final concen- 
tration). Each sample was incubated at 37°C for 30 min and reaction 
was stopped by 10% TCA (trichloroacetic acid). After centrifugation 
at 500 x g for 15 min, 100 ml of sample was mixed with 200 ml of a 
MO-reagent (2.5% ammonium molybdate/5 N H,SO,) and 300 ml of 
10% L-ascorbic acid. After incubation at 30°C for 10 min, the liberated 
phosphate was measured at 660 nm (Hitachi spectrophotometer 
F3000). 
Fig. I. Nucleotide and amino acid sequences of human MtPK. The complete alignment of human MtPK cDNA is shown, together with the predicted 
protein sequence. The ATG start codon and TGA termination codon are shown by reversed letters. The box highlights the 5 x CTG repeat. 
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Fig. 2. Comparison of the N-terminal amino acid sequence deduced from the nucleotide sequence of MtPK with sequences of thymopoietins (TPs). 
Lines: 1, human MtPK; 2, bovine TP-I; 3, bovine TP-II; 4, bovine splenin; 5, human TP; 6, human splenin. Reversed letters indicate residues where 
at least one other peptide shows identity. Peptide sequence with T-cell differentiation activity is underlined. 
3. Results and discussion 
Fig. I shows the nucleotide and deduced amino acid 
sequences of a newly-isolated full-length MtPK cDNA 
clone. The sequence is essentially identical to that previ- 
ously described, but differs slightly near the termination 
codon. The termination codon is at nucleotide 1,876 
rather than at 1,869 [2] or 1,913 [7,16]; the putative mo- 
lecular weight was calculated as 69,617 Da, close to the 
reported value [8,16]. 
A computer search of the protein data base indicates 
that the N-terminal amino acid sequence predicted from 
the nucleotide sequence of MtPK shows a considerable 
degree of similarity to many previously sequenced thy- 
mopoietins (TPs), a 49-amino acid (48- for human) 
hormone of the thymus with pleiotropic actions on 
prothymocytes, mature T-cells and nicotinic receptors 
[17,18]. Recent report casts doubt about interaction of 
TP with both the muscle- and neuronal-type nicotinic 
a-bungarotoxin receptors [ 191. These include bovine 
TPs, splenin and their human counterparts. Fig. 2 shows 
the sequence alignment of bovine TPs, human TP and 
splenins with the amino acid sequence predicted from 
MtPK cDNA clone. The N- terminal domain of MtPK 
(1 l-60) shows approximately 32% amino acid identities 
to the entire region of TPs. These sequence similarities 
between MtPK and other known TPs may suggest a 
specific role of MtPK in immune cells. However, because 
the similarity between MtPK and TPs was not so high, 
we were unable to use the sequence data to predict the 
hormonal function of the MtPK coded by a novel 
cDNA. The isolation of MtPK should contribute to the 
further understanding of this protein in DM. 
This MtPK cDNA clone was inserted into a pSRD 
vector, and transfected into COS cells. The transfected 
COS cells produced a 70 kDa protein identical to the 
estimated value (Fig. 3). This protein localized exclu- 
sively to the supernatant fraction. No degradation prod- 
ucts were observed in the COS-extracts. In addition, 
endogenous MtPK was not detectable in COS-1 cells. 
Anti-DMl was used as the first antibody in these exper- 
iments. Anti-DM5 did not crossreact with the 70 kDa 
protein. These results suggest that the sequence of pep- 
tide DMl is certainly involved in the expressed protein 
whereas the frame-shift product, derived from the se- 
quence published in [2], is not a translational product 
from MtPK mRNA. 
The MtPK cDNA clone shows a sequence conserved 
among Ser/Thr protein kinases. In order to determine 
whether the 70 kDa protein is a protein kinase, its kinase 
activity was examined. CAMP-dependent and/or cal- 
cium-dependent protein kinase activities were deter- 
mined using 32P-labeled ATP and casein as substrates. So 
far we have been unable to detect protein kinase activi- 
ties. Autophosphorylation of the 70 kDa protein was 
also measured. After incubation of the COS-1 superna- 
tant with 32P-ATP and Mg’+, the proteins were im- 
munoprecipitated with anti-DM 1 and electrophoresed. 
No increase in the intensity of the band corresponding 
to molecular weight about 70 kDa was observed. ATP- 
Ml2 34 
Fig. 3. Immunoblotting of cDNA-transfected COS cell extracts. 
Freshly prepared COS-1 cells were homogenized with a Dounce ho- 
mogenizer, and the homogenate was centrifuged at 15,000 xg for IO 
min. The resultant precipitate (lanes 1 and 2) and supernatant (lanes 
3 and 4) were solubilized with 2% SDS and electrophoresed in 10% SDS 
gels. Fractionated proteins from MtPK cDNA-transfected (lanes 1 and 
3) and vector-transfected (lanes 2 and 4) COS-1 cells are shown. Several 
non-specific bands can be observed in this blot; however, these bands 
disappeared when antibody against the E. co&generated C-terminus 
portion of MtPK (from nucleotide 1,246 to the C-terminus, K. 
Maruyama, unpublished results) was used as a primary antibody. Ex- 
pressed MtPK is indicated by an arrowhead. M, low-molecular-weight 
markers, phosphorylase b (94 kDa), bovine serum albumin (67 kDd), 
ovalbumin (43 kDa), carbonicanhydrase (30 kDa), trypsin inhibitor (20 
kDa) and lactoalbumin (14 kDa). 
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Fig. 4. Expression of MtPK in adult rat tissues. Ten micrograms of 
protein from rat tissue extracts were applied to each lane and visualized 
by anti-DMI antibody after immunoblotting(lO% SDS gel). Crossreac- 
tive proteins with anti-DMI and anti-DM2 (data not shown) are desig- 
nated by arrowheads. Lane M, marker proteins as described in Fig. 2. 
Lane I, cardiac muscle; lane 2, brain; lane 3, liver; lane 4, lung. 
ase activity was also determined in the presence and 
absence of Ca2’, Mg*+, K’ and Na+, since the nucleotide 
sequence of MtPK appeared to be similar to that of 
myosin [2]. Only a 1.2-fold increase in ATPase activity 
was observed in 0.1 M Na’ solution. Autophosphoryla- 
tion of endogenous MtPK was not observed in cells la- 
beled with 32P-orthophosphate and immunoprecipitated 
with anti-DMl. These results indicate that the 70 kDa 
MtPK protein is inactive under the assay conditions 
used. Specific co-factor(s) or MtPK processing might be 
required for activation. 
As shown in Fig. 4, Western blot analysis of cytosolic 
proteins with anti-DMI showed a full-length MtPK (70 
kDa) and a shorter processed polypeptide (43 kDa) to be 
present in cardiac muscle. The latter 43 kDa band disap- 
peared when anti-DM2 was used as a primary antibody 
(unpublished results), indicating that this band was not 
a protein product of a MtPK gene. Longer polypeptides 
were also detected in liver and lung extracts. There are 
several reports indicating that a 54 kDa or 55 kDa pro- 
tein is recognized by anti-MtPK antibody [lo, 151. There- 
fore the low-molecular weight MtPK protein found in 
this and previous reports might have arisen through 
some modifications or degradation of the full-length pre- 
cursor to an active form. 
Korneluk et al. suggested that there are two mRNA 
isoforms of MtPK, one coding a protein of 69 kDa (skel- 
etal isoform) and the other a protein of 60 kDa (cardiac 
isoform) [14]. Therefore, alternative splicing of MtPK 
mRSA might occur. This alternative splicing may also 
play a role in the function of MtPK. The level of the 
expressed 70 kDa protein was significantly lower than 
that usually observed for transfections of other cDNAs 
by the same method. Therefore, the stability of the ex- 
pressed MtPK 70 kDa protein must be considered. 
Myotonia is clinical feature of DM [l]. Biochemical 
features include membrane abnormalities, decreased 
phosphorylation of membrane-bound proteins, changes 
in the Ca”-permeability of erythrocyte ghosts, a modu- 
lation of ATPase activity, and a decrease in membrane 
fluidity. It therefore appears that DM is a systemic dis- 
ease of neuromuscular transmission and/or signal 
transduction. MtPK may play an important role in these 
functions [20]. If so, either increased or decreased expres- 
sion of MtPK in tissue can cause myotonia, an abnor- 
mality of neuromuscular transmission. 
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